RNAi screening identifies KAT8 as a key molecule important for cancer cell survival
Related Experiment Video
Updated: May 11, 2026

MISSION LentiPlex Pooled shRNA Library Screening in Mammalian Cells
Published on: December 21, 2011
Shuang Zhang1, Xianhong Liu, Yong Zhang
1Department of Pathophysiology, Norman Bathune College of Medical Sciences, Jilin University, Changchun, China.
Abstract:
Histone acetyltransferases (HATs) regulate many critical cancer events, including transcriptional regulation of oncogene and tumor suppressors, chromatin structure and DNA damage response. Abnormal expression of HATs has been reported in a number of cancers. However, cellular functions of HATs in cancer and molecular mechanisms remain largely unclear. Here, we performed a lentiviral vector-mediated RNAi screen to systematically address the function of HATs in lung cancer cell growth and viability. We identified 8 HATs genes involved in A549 cell viability. Further experiments showed that KAT8 regulates G2/M cell cycle arrest through AKT/ERK-cyclin D1 signaling. Moreover, KAT8 inhibition led to p53 induction and subsequently reduced bcl-2 expression. Our results demonstrate an important role of KAT8 in cancer and suggest that KAT8 could be a novel cancer therapeutic target.
Insights
Histone acetyltransferases (HATs) are crucial in cancer. This study identifies KAT8 as a key regulator of lung cancer cell viability, suggesting it as a potential therapeutic target.
Area of Science:
- Molecular Biology
- Cancer Research
- Epigenetics
Background:
- Histone acetyltransferases (HATs) play vital roles in cancer by regulating gene expression, chromatin structure, and DNA repair.
- Aberrant HAT expression is observed in various cancers, but their specific functions and mechanisms in cancer remain poorly understood.
- Understanding HATs' roles is critical for developing novel cancer therapies.
Purpose of the Study:
- To systematically investigate the function of HATs in lung cancer cell growth and viability using a large-scale RNAi screen.
- To elucidate the molecular mechanisms by which specific HATs influence cancer progression.
- To identify potential therapeutic targets within the HAT family for lung cancer treatment.
Main Methods:
- Conducted a lentiviral vector-mediated RNA interference (RNAi) screen to assess the impact of HAT genes on A549 lung cancer cell viability.
- Performed further experiments to validate the role of identified HATs, focusing on KAT8.
- Utilized molecular assays to investigate signaling pathways, cell cycle regulation, and apoptosis-related gene expression.
Main Results:
- Identified eight HAT genes that significantly affect A549 cell viability.
- Demonstrated that KAT8 regulates G2/M cell cycle arrest via the AKT/ERK-cyclin D1 signaling pathway.
- Showed that KAT8 inhibition induces p53 and reduces bcl-2 expression, indicating an impact on apoptosis.
Conclusions:
- KAT8 plays a significant role in regulating lung cancer cell viability and progression.
- The findings highlight KAT8 as a potential novel therapeutic target for cancer treatment.
- Further research into KAT8-mediated pathways could lead to targeted cancer therapies.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
lncRNA - Long Non-coding RNAs
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Ras Gene
Ras is a superfamily...
Experimental RNAi
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
